MarginsXMarginsX
Home › Markets › GLAXF

GSK plc (GLAXF)

GLAXF is quoted over the counter, not listed on an exchange. GSK plc files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · November 11, 2026
$25.23
No trades since Nov 11, 2026; later closes repeat the last quote
1-year return
+10.9%
Market cap
The company also trades on NYSE as GSK; this OTC line is another class or a foreign line, so its cap is not computed
P/E and P/S
Needs a market cap · Needs a market cap
On fiscal year to December 31, 2025 (20-F)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerGLAXF, quoted over the counter
SEC CIK0001131399
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressLondon
Incorporated inUnited Kingdom

Warning signs

Cash runway
Cash-flow positive
3.4B GBP cash at December 31, 2025
Share count, 1 year
0.0%
2024-12-31 to 2025-12-31 · +0.1% over 3 years
Going-concern doubt
No
20-F filed March 6, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-03-06
Cash and burn3.4B GBP cash; operating cash flow 1.9B GBP a quarter.Report 2025-12-31
Shares outstanding2,157,722,513 (2025-12-31); 2,157,151,867 a year earlier; 2,155,671,671 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2025-05-15
AuditorDeloitte LLP, London, United KingdomPCAOB Form AP 2026-03-30
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
32.7B GBP5.7B GBP7.7B GBP3.4B GBP14.5B GBP32.7B GBP20-F 2026-03-06
FY 2024
2024-12-31
31.4B GBP2.6B GBP6.6B GBP3.9B GBP13.1B GBP31.4B GBP20-F 2026-03-06
FY 2023
2023-12-31
30.3B GBP4.9B GBP6.8B GBP2.9B GBP15.0B GBP30.3B GBP20-F 2025-03-03
FY 2022
2022-12-31
29.3B GBP15.0B GBP7.4B GBP3.7B GBP17.2B GBP29.3B GBP20-F 2024-03-05
FY 2021
2021-12-31
24.7B GBP4.4B GBP8.0B GBP4.3B GBP19.8B GBP24.7B GBP20-F 2024-03-05
FY 2020
2020-12-31
24.4B GBP5.7B GBP8.4B GBP6.3B GBP20.8B GBP24.4B GBP20-F 2023-03-10
FY 2019
2019-12-31
33.8B GBP4.6B GBP8.0B GBP4.7B GBP25.2B GBP33.8B GBP20-F 2022-03-08
FY 2018
2018-12-31
30.8B GBP3.6B GBP8.4B GBP3.9B GBP21.6B GBP30.8B GBP20-F 2021-03-12

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in GBP.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B22026-09-10
Latest annual report20-F2026-03-06
Latest quarterly / interim6-K2026-11-13

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier